4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-010601
EVP, CHIEF FINANCIAL OFFICER sold 2,716 shares at $17.87 ($48,535)
- EVP, CHIEF FINANCIAL OFFICER acquired 5,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-04-05 | Option exercise | +5,275 | 31,458 | D | ||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-04-08 | Sale | −2,716 | $17.87 | $48,535 | 28,742 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2024-04-05 | Option exercise · Restricted Stock Units | −5,275 | 10,551 | D | ||
| Open-market sales · 2,716 sh · avg $17.87 · $48,535 | |||||||
Loading xslF345X05/form4-04092024_060401.xml…